Mesenteric paraganglioma: the case of mistaken identity
Athina Pirpiris MBBS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorMax Fu MBBS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorJoel Budge BSc (Med), MBBS, FRACS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorSoni Putnis MBChB, BSc, FRCS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorAthina Pirpiris MBBS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorMax Fu MBBS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorJoel Budge BSc (Med), MBBS, FRACS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this authorSoni Putnis MBChB, BSc, FRCS
Colorectal Department, Wollongong Hospital, Wollongong, New South Wales, Australia
Search for more papers by this author
References
- 1Jaffer S, Harpaz N. Mesenteric paraganglioma: a case report and review of the literature. Arch. Pathol. Lab. Med. 2002; 126: 362–364.
- 2Bhatt S, Vanderlinde S, Farag R et al. Pararectal paraganglioma. Br. J. Radiol. 2007; 80: e253–256.
- 3Fujita T, Kamiya K, Takahashi Y et al. Mesenteric paraganglioma: report of a case. World J. Gastrointest. Surg. 2013; 5: 62–67.
- 4van Duinen N, Kema I, Romijn J et al. Plasma chromogranin A levels are increased in a small portion of patients with hereditary head and neck paragangliomas. Clin. Endocrinol. (Oxf.) 2011; 74: 160–165.
- 5Hanson M. Scintigraphic evaluation of neuroendocrine tumours. Appl. Radiol. 2001; 30: 1–4.
10.1016/S0160-9963(01)80204-1 Google Scholar
- 6Telischi F, Bustillo A, Whiteman M et al. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol. Head Neck Surg. 2000; 122: 358–362.
- 7Sahdev A, Sohaib A, Monson J et al. CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas). Eur. Radiol. 2005; 15: 85–92.
- 8Motta-Ramirez G, Remer E, Herts B et al. Comparison of CT findings in symptomatic and incidentally discovered phaeochromocytomas. AJR Am. J. Roentgenol. 2005; 185: 684–688.
- 9Ilias I, Yu J, Carrasquillo J et al. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J. Clin. Endocrinol. Metab. 2003; 88: 4083–4087.
- 10Mamede M, Carrasquillo J, Chen C et al. Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine-and ((123)I)-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl. Med. Commun. 2006; 27: 31–36.
Citing Literature
